| 0 |
INSULIN-LIKE GROWTH FACTOR ABNORMAL |
70 |
0.6195 |
| 1 |
GROWTH HORMONE-PRODUCING PITUITARY TUMOUR |
18 |
0.5625 |
| 2 |
ENDOCRINE GLAND OPERATION |
3 |
0.3000 |
| 3 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
380 |
0.2663 |
| 4 |
BLOOD GROWTH HORMONE INCREASED |
135 |
0.2419 |
| 5 |
INTERFERON GAMMA DECREASED |
2 |
0.2222 |
| 6 |
PITUITARY GLAND OPERATION |
6 |
0.2000 |
| 7 |
PITUITARY STALK INTERRUPTION SYNDROME |
2 |
0.1333 |
| 8 |
ACROMEGALY |
41 |
0.1293 |
| 9 |
INTERFERON GAMMA LEVEL INCREASED |
2 |
0.1176 |
| 10 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
58 |
0.1096 |
| 11 |
PITUITARY TUMOUR RECURRENT |
19 |
0.1092 |
| 12 |
INJECTION SITE HYPERTROPHY |
28 |
0.0859 |
| 13 |
PROGNATHISM |
8 |
0.0851 |
| 14 |
BLOOD GONADOTROPHIN DECREASED |
2 |
0.0800 |
| 15 |
ANORECTAL POLYP |
8 |
0.0748 |
| 16 |
BLOOD GROWTH HORMONE ABNORMAL |
9 |
0.0738 |
| 17 |
HYPERPITUITARISM |
2 |
0.0645 |
| 18 |
BLOOD PROLACTIN DECREASED |
11 |
0.0629 |
| 19 |
BLOOD TESTOSTERONE FREE DECREASED |
8 |
0.0611 |
| 20 |
LIPOHYPERTROPHY |
37 |
0.0595 |
| 21 |
ENDOCRINE TEST ABNORMAL |
2 |
0.0588 |
| 22 |
SENSITISATION |
42 |
0.0553 |
| 23 |
FIBROUS DYSPLASIA OF BONE |
4 |
0.0541 |
| 24 |
SHUNT MALFUNCTION |
15 |
0.0530 |
| 25 |
GASTRIC HYPOMOTILITY |
15 |
0.0489 |
| 26 |
PITUITARY TUMOUR |
72 |
0.0483 |
| 27 |
ABNORMAL ORGAN GROWTH |
2 |
0.0455 |
| 28 |
PITUITARY ENLARGEMENT |
9 |
0.0441 |
| 29 |
VIRAL DIARRHOEA |
15 |
0.0436 |
| 30 |
OXALOSIS |
3 |
0.0395 |
| 31 |
LARYNGITIS BACTERIAL |
2 |
0.0377 |
| 32 |
RECTAL POLYP |
35 |
0.0355 |
| 33 |
BLOOD LUTEINISING HORMONE DECREASED |
6 |
0.0335 |
| 34 |
PITUITARY TUMOUR BENIGN |
54 |
0.0331 |
| 35 |
INJECTION SITE EROSION |
11 |
0.0312 |
| 36 |
DEFICIENCY OF BILE SECRETION |
3 |
0.0300 |
| 37 |
FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III |
2 |
0.0299 |
| 38 |
DEVICE CHEMICAL PROPERTY ISSUE |
2 |
0.0299 |
| 39 |
NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED |
8 |
0.0296 |
| 40 |
SHUNT OCCLUSION |
15 |
0.0295 |
| 41 |
RENAL HAEMATOMA |
15 |
0.0292 |
| 42 |
BONE DENSITY INCREASED |
11 |
0.0276 |
| 43 |
INFECTED DERMAL CYST |
9 |
0.0249 |
| 44 |
VISUAL PATHWAY DISORDER |
4 |
0.0248 |
| 45 |
BLOOD GROWTH HORMONE DECREASED |
5 |
0.0248 |
| 46 |
VITAL FUNCTIONS ABNORMAL |
20 |
0.0234 |
| 47 |
BLOOD FOLLICLE STIMULATING HORMONE DECREASED |
4 |
0.0227 |
| 48 |
PITUITARY TUMOUR REMOVAL |
2 |
0.0211 |
| 49 |
CHANGE OF BOWEL HABIT |
43 |
0.0209 |
| 50 |
VERY LOW DENSITY LIPOPROTEIN INCREASED |
4 |
0.0180 |
| 51 |
HYSTEROSALPINGO-OOPHORECTOMY |
2 |
0.0179 |
| 52 |
OSTEOCHONDROMA |
2 |
0.0168 |
| 53 |
ALBUMIN GLOBULIN RATIO DECREASED |
3 |
0.0129 |
| 54 |
MINIMAL RESIDUAL DISEASE |
6 |
0.0124 |
| 55 |
INJECTION SITE OEDEMA |
21 |
0.0122 |
| 56 |
CENTRAL OBESITY |
9 |
0.0122 |
| 57 |
PELVIC FLOOR MUSCLE WEAKNESS |
2 |
0.0117 |
| 58 |
POLYP |
75 |
0.0114 |
| 59 |
INTRACARDIAC MASS |
2 |
0.0113 |
| 60 |
FAT TISSUE INCREASED |
16 |
0.0110 |
| 61 |
ECLAMPSIA |
4 |
0.0109 |
| 62 |
IMPAIRED FASTING GLUCOSE |
3 |
0.0098 |
| 63 |
URINE ABNORMALITY |
43 |
0.0094 |
| 64 |
GROWTH ACCELERATED |
2 |
0.0093 |
| 65 |
EMPTY SELLA SYNDROME |
2 |
0.0092 |
| 66 |
LIPODYSTROPHY ACQUIRED |
19 |
0.0089 |
| 67 |
CRANIOFACIAL DEFORMITY |
2 |
0.0086 |
| 68 |
HYPOTHALAMO-PITUITARY DISORDER |
12 |
0.0082 |
| 69 |
BLOOD CHOLESTEROL ABNORMAL |
38 |
0.0082 |
| 70 |
CAVERNOUS SINUS THROMBOSIS |
2 |
0.0079 |
| 71 |
THYROXINE FREE INCREASED |
5 |
0.0078 |
| 72 |
BREAST DISORDER FEMALE |
2 |
0.0078 |
| 73 |
URINE ODOUR ABNORMAL |
45 |
0.0076 |
| 74 |
NASAL SEPTUM DISORDER |
2 |
0.0075 |
| 75 |
ACOUSTIC NEUROMA |
3 |
0.0073 |
| 76 |
FRUSTRATION TOLERANCE DECREASED |
58 |
0.0072 |
| 77 |
THYROXINE FREE DECREASED |
4 |
0.0071 |
| 78 |
NEEDLE ISSUE |
204 |
0.0070 |
| 79 |
MALOCCLUSION |
2 |
0.0068 |
| 80 |
PROCTALGIA |
42 |
0.0065 |
| 81 |
PITUITARY HAEMORRHAGE |
2 |
0.0065 |
| 82 |
ADRENAL NEOPLASM |
3 |
0.0064 |
| 83 |
CALCINOSIS |
14 |
0.0063 |
| 84 |
POSTOPERATIVE WOUND INFECTION |
42 |
0.0062 |
| 85 |
BREATH ODOUR |
15 |
0.0061 |
| 86 |
CORTISOL DECREASED |
7 |
0.0061 |
| 87 |
BODY HEIGHT INCREASED |
3 |
0.0061 |
| 88 |
DUODENAL ULCER |
43 |
0.0061 |
| 89 |
INFREQUENT BOWEL MOVEMENTS |
15 |
0.0060 |
| 90 |
ADENOMA BENIGN |
5 |
0.0058 |
| 91 |
TRI-IODOTHYRONINE DECREASED |
3 |
0.0057 |
| 92 |
MUSCLE HYPERTROPHY |
2 |
0.0057 |
| 93 |
FURUNCLE |
45 |
0.0057 |
| 94 |
HELICOBACTER INFECTION |
57 |
0.0055 |
| 95 |
LACTOSE INTOLERANCE |
14 |
0.0055 |
| 96 |
BODY DYSMORPHIC DISORDER |
2 |
0.0053 |
| 97 |
SOFT TISSUE SWELLING |
3 |
0.0053 |
| 98 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
24 |
0.0053 |
| 99 |
INJECTION SITE DISCOMFORT |
54 |
0.0051 |
| 100 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
10 |
0.0051 |
| 101 |
STRABISMUS |
15 |
0.0051 |
| 102 |
DEVICE COLOUR ISSUE |
2 |
0.0050 |
| 103 |
HYPOGONADISM |
5 |
0.0049 |
| 104 |
FAECES PALE |
11 |
0.0049 |
| 105 |
BLOOD BILIRUBIN DECREASED |
3 |
0.0049 |
| 106 |
THYROXINE DECREASED |
3 |
0.0048 |
| 107 |
EXOSTOSIS |
44 |
0.0048 |
| 108 |
CORTISOL INCREASED |
3 |
0.0048 |
| 109 |
NEOPLASM |
54 |
0.0047 |
| 110 |
RUBBER SENSITIVITY |
7 |
0.0046 |
| 111 |
PHONOPHOBIA |
2 |
0.0043 |
| 112 |
BLADDER DISORDER |
42 |
0.0042 |
| 113 |
OCULAR NEOPLASM |
2 |
0.0042 |
| 114 |
BLOOD TESTOSTERONE INCREASED |
9 |
0.0042 |
| 115 |
LAZINESS |
7 |
0.0041 |
| 116 |
BLOOD TESTOSTERONE DECREASED |
28 |
0.0041 |
| 117 |
HYPOPITUITARISM |
7 |
0.0040 |
| 118 |
BRAIN NEOPLASM |
36 |
0.0039 |
| 119 |
HORMONE LEVEL ABNORMAL |
19 |
0.0039 |
| 120 |
ASPARTATE AMINOTRANSFERASE DECREASED |
2 |
0.0038 |
| 121 |
DIABETES INSIPIDUS |
9 |
0.0037 |
| 122 |
TUMOUR EXCISION |
3 |
0.0037 |
| 123 |
CONCOMITANT DISEASE AGGRAVATED |
23 |
0.0037 |
| 124 |
NEOPLASM RECURRENCE |
12 |
0.0035 |
| 125 |
COLONIC ABSCESS |
3 |
0.0035 |
| 126 |
LOW DENSITY LIPOPROTEIN INCREASED |
27 |
0.0035 |
| 127 |
THYROID DISORDER |
53 |
0.0034 |
| 128 |
PERIPHERAL COLDNESS |
47 |
0.0034 |
| 129 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
3 |
0.0034 |
| 130 |
WEIGHT ABNORMAL |
8 |
0.0033 |
| 131 |
DEVICE CONNECTION ISSUE |
7 |
0.0033 |
| 132 |
GALLBLADDER DISORDER |
59 |
0.0033 |
| 133 |
MASS |
46 |
0.0033 |
| 134 |
POOR QUALITY PRODUCT ADMINISTERED |
34 |
0.0032 |
| 135 |
BLOOD PROLACTIN INCREASED |
15 |
0.0032 |
| 136 |
BLOOD PRESSURE SYSTOLIC INCREASED |
62 |
0.0032 |
| 137 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
3 |
0.0032 |
| 138 |
BILE DUCT OBSTRUCTION |
6 |
0.0032 |
| 139 |
BLOOD CORTISOL DECREASED |
2 |
0.0031 |
| 140 |
OESOPHAGEAL ACHALASIA |
2 |
0.0031 |
| 141 |
BILIARY COLIC |
9 |
0.0031 |
| 142 |
BLOOD GLUCOSE FLUCTUATION |
33 |
0.0030 |
| 143 |
DEVICE PHYSICAL PROPERTY ISSUE |
23 |
0.0030 |
| 144 |
MAMMOGRAM ABNORMAL |
2 |
0.0030 |
| 145 |
BRONCHITIS VIRAL |
2 |
0.0030 |
| 146 |
HEART RATE DECREASED |
104 |
0.0030 |
| 147 |
BLOOD CHLORIDE INCREASED |
5 |
0.0029 |
| 148 |
INJECTION SITE INJURY |
16 |
0.0029 |
| 149 |
SKIN HYPERTROPHY |
8 |
0.0028 |
| 150 |
BILE DUCT STONE |
9 |
0.0028 |
| 151 |
ALPHA 1 FOETOPROTEIN INCREASED |
2 |
0.0028 |
| 152 |
NEOPLASM PROGRESSION |
96 |
0.0028 |
| 153 |
MUSCULOSKELETAL DISCOMFORT |
47 |
0.0027 |
| 154 |
BILIARY DILATATION |
4 |
0.0027 |
| 155 |
CEREBROSPINAL FLUID LEAKAGE |
5 |
0.0027 |
| 156 |
BONE DISORDER |
49 |
0.0027 |
| 157 |
CHOLELITHIASIS |
88 |
0.0027 |
| 158 |
CARBON DIOXIDE DECREASED |
3 |
0.0026 |
| 159 |
HEPATIC ENZYME ABNORMAL |
13 |
0.0026 |
| 160 |
BLOOD CREATININE DECREASED |
8 |
0.0026 |
| 161 |
ARTERIAL OCCLUSIVE DISEASE |
20 |
0.0025 |
| 162 |
DEVICE DISPENSING ERROR |
3 |
0.0025 |
| 163 |
BILE DUCT CANCER |
3 |
0.0025 |
| 164 |
INJECTION SITE MASS |
92 |
0.0025 |
| 165 |
LIQUID PRODUCT PHYSICAL ISSUE |
18 |
0.0025 |
| 166 |
BLOOD PARATHYROID HORMONE INCREASED |
7 |
0.0024 |
| 167 |
HIGH DENSITY LIPOPROTEIN DECREASED |
8 |
0.0024 |
| 168 |
SYRINGE ISSUE |
42 |
0.0024 |
| 169 |
NECK INJURY |
7 |
0.0024 |
| 170 |
THYROID MASS |
9 |
0.0023 |
| 171 |
FAECES SOFT |
17 |
0.0023 |
| 172 |
NOCTURIA |
28 |
0.0023 |
| 173 |
POLYDIPSIA |
9 |
0.0023 |
| 174 |
SPINAL OSTEOARTHRITIS |
20 |
0.0023 |
| 175 |
SLEEP APNOEA SYNDROME |
42 |
0.0022 |
| 176 |
GOITRE |
9 |
0.0022 |
| 177 |
CLUSTER HEADACHE |
3 |
0.0022 |
| 178 |
EYE MOVEMENT DISORDER |
15 |
0.0022 |
| 179 |
BLOOD PRESSURE DIASTOLIC INCREASED |
10 |
0.0022 |
| 180 |
PREMATURE MENOPAUSE |
2 |
0.0022 |
| 181 |
INJECTION SITE CELLULITIS |
4 |
0.0022 |
| 182 |
SNORING |
8 |
0.0021 |
| 183 |
LIPOATROPHY |
2 |
0.0021 |
| 184 |
WOUND INFECTION |
23 |
0.0021 |
| 185 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
53 |
0.0021 |
| 186 |
FULL BLOOD COUNT DECREASED |
42 |
0.0021 |
| 187 |
FAECES DISCOLOURED |
45 |
0.0021 |
| 188 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
35 |
0.0020 |
| 189 |
SKIN STRIAE |
3 |
0.0020 |
| 190 |
HAEMANGIOMA OF LIVER |
2 |
0.0020 |
| 191 |
BLOOD CHLORIDE DECREASED |
5 |
0.0019 |
| 192 |
BODY TEMPERATURE DECREASED |
19 |
0.0019 |
| 193 |
DIABETES MELLITUS |
147 |
0.0019 |
| 194 |
AXILLARY MASS |
2 |
0.0019 |
| 195 |
RENAL CYST |
15 |
0.0019 |
| 196 |
ALLERGY TO ANIMAL |
2 |
0.0019 |
| 197 |
OBSESSIVE-COMPULSIVE DISORDER |
15 |
0.0019 |
| 198 |
INJECTION SITE ATROPHY |
3 |
0.0018 |
| 199 |
THYROID NEOPLASM |
5 |
0.0018 |
| 200 |
CHOLECYSTITIS INFECTIVE |
5 |
0.0018 |
| 201 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
3 |
0.0018 |
| 202 |
MUSCLE RUPTURE |
7 |
0.0018 |
| 203 |
BRAIN INJURY |
18 |
0.0018 |
| 204 |
POOR QUALITY DEVICE USED |
18 |
0.0018 |
| 205 |
ESSENTIAL TREMOR |
2 |
0.0018 |
| 206 |
CLEFT LIP AND PALATE |
2 |
0.0018 |
| 207 |
JAUNDICE |
48 |
0.0018 |
| 208 |
LIMB DISCOMFORT |
55 |
0.0018 |
| 209 |
INJECTION SITE SCAR |
5 |
0.0018 |
| 210 |
INJECTION SITE BRUISING |
139 |
0.0017 |
| 211 |
LICHEN PLANUS |
4 |
0.0017 |
| 212 |
DILATATION ATRIAL |
2 |
0.0017 |
| 213 |
GROIN ABSCESS |
2 |
0.0017 |
| 214 |
GLUCOSE TOLERANCE IMPAIRED |
10 |
0.0017 |
| 215 |
LABILE BLOOD PRESSURE |
2 |
0.0017 |
| 216 |
RED CELL DISTRIBUTION WIDTH INCREASED |
7 |
0.0017 |
| 217 |
DEVICE LEAKAGE |
73 |
0.0017 |
| 218 |
PRODUCT PREPARATION ISSUE |
11 |
0.0017 |
| 219 |
TOOTH ABSCESS |
17 |
0.0017 |
| 220 |
PRODUCT DOSE OMISSION IN ERROR |
47 |
0.0017 |
| 221 |
MEAN CELL HAEMOGLOBIN DECREASED |
3 |
0.0016 |
| 222 |
HEPATIC ENZYME INCREASED |
111 |
0.0016 |
| 223 |
FOOT DEFORMITY |
18 |
0.0016 |
| 224 |
INJECTION SITE INDURATION |
21 |
0.0016 |
| 225 |
INJECTION SITE ABSCESS |
4 |
0.0016 |
| 226 |
CHOLECYSTITIS ACUTE |
9 |
0.0016 |
| 227 |
POLYURIA |
13 |
0.0016 |
| 228 |
ENDOCRINE DISORDER |
2 |
0.0016 |
| 229 |
CALCIUM DEFICIENCY |
2 |
0.0015 |
| 230 |
BILIARY OBSTRUCTION |
2 |
0.0015 |
| 231 |
VITAMIN D DECREASED |
13 |
0.0015 |
| 232 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
2 |
0.0015 |
| 233 |
PYELONEPHRITIS |
13 |
0.0015 |
| 234 |
TRIGEMINAL NEURALGIA |
6 |
0.0015 |
| 235 |
LIPIDS INCREASED |
3 |
0.0015 |
| 236 |
POSTPARTUM HAEMORRHAGE |
2 |
0.0015 |
| 237 |
CARBON DIOXIDE INCREASED |
2 |
0.0015 |
| 238 |
CALCULUS BLADDER |
2 |
0.0015 |
| 239 |
CHEST INJURY |
3 |
0.0014 |
| 240 |
TENDONITIS |
22 |
0.0014 |
| 241 |
URINARY INCONTINENCE |
42 |
0.0014 |
| 242 |
LOW DENSITY LIPOPROTEIN DECREASED |
2 |
0.0014 |
| 243 |
MUSCULOSKELETAL PAIN |
74 |
0.0014 |
| 244 |
BONE PAIN |
82 |
0.0014 |
| 245 |
EXOPHTHALMOS |
3 |
0.0014 |
| 246 |
POST HERPETIC NEURALGIA |
2 |
0.0014 |
| 247 |
HORDEOLUM |
6 |
0.0014 |
| 248 |
MUTISM |
2 |
0.0014 |
| 249 |
MONOCYTE COUNT INCREASED |
5 |
0.0014 |
| 250 |
LIMB MASS |
3 |
0.0014 |
| 251 |
BLOOD PRESSURE INCREASED |
206 |
0.0013 |
| 252 |
CHOLANGIOCARCINOMA |
2 |
0.0013 |
| 253 |
LUNG NEOPLASM MALIGNANT |
55 |
0.0013 |
| 254 |
BLOOD GLUCOSE DECREASED |
64 |
0.0013 |
| 255 |
DYSURIA |
49 |
0.0013 |
| 256 |
HEPATOCELLULAR DAMAGE |
3 |
0.0013 |
| 257 |
ASTIGMATISM |
2 |
0.0013 |
| 258 |
HAEMATOCRIT INCREASED |
3 |
0.0013 |
| 259 |
HEAT STROKE |
2 |
0.0013 |
| 260 |
HYPERTROPHIC CARDIOMYOPATHY |
2 |
0.0013 |
| 261 |
PRODUCT DEPOSIT |
2 |
0.0013 |
| 262 |
INJECTION SITE HYPERSENSITIVITY |
4 |
0.0013 |
| 263 |
JAW DISORDER |
7 |
0.0013 |
| 264 |
DEVICE DEFECTIVE |
22 |
0.0013 |
| 265 |
MYOPIA |
3 |
0.0013 |
| 266 |
PANNICULITIS |
3 |
0.0012 |
| 267 |
INJECTION SITE INFLAMMATION |
6 |
0.0012 |
| 268 |
ANXIETY DISORDER |
4 |
0.0012 |
| 269 |
BLOOD TRIGLYCERIDES INCREASED |
21 |
0.0012 |
| 270 |
LABYRINTHITIS |
3 |
0.0012 |
| 271 |
FEELING COLD |
33 |
0.0012 |
| 272 |
EATING DISORDER |
25 |
0.0012 |
| 273 |
LACK OF INJECTION SITE ROTATION |
2 |
0.0011 |
| 274 |
ERUCTATION |
22 |
0.0011 |
| 275 |
AORTIC VALVE STENOSIS |
2 |
0.0011 |
| 276 |
BLOOD SODIUM INCREASED |
3 |
0.0011 |
| 277 |
ARTHRITIS |
87 |
0.0011 |
| 278 |
HAEMOGLOBIN INCREASED |
5 |
0.0011 |
| 279 |
BLOOD IRON DECREASED |
13 |
0.0011 |
| 280 |
RHINALGIA |
3 |
0.0011 |
| 281 |
PRODUCT USE ISSUE |
203 |
0.0011 |
| 282 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 283 |
SCIATICA |
17 |
0.0011 |
| 284 |
GASTROENTERITIS VIRAL |
19 |
0.0011 |
| 285 |
PANCREATIC CYST |
2 |
0.0010 |
| 286 |
ADRENAL DISORDER |
2 |
0.0010 |
| 287 |
HEPATIC MASS |
2 |
0.0010 |
| 288 |
FINE MOTOR SKILL DYSFUNCTION |
3 |
0.0010 |
| 289 |
BLOOD CHOLESTEROL INCREASED |
48 |
0.0010 |
| 290 |
BLOOD GLUCOSE ABNORMAL |
19 |
0.0010 |
| 291 |
AFFECTIVE DISORDER |
8 |
0.0010 |
| 292 |
BLOOD TEST ABNORMAL |
14 |
0.0010 |
| 293 |
PRODUCT SOLUBILITY ABNORMAL |
5 |
0.0010 |
| 294 |
LIBIDO INCREASED |
2 |
0.0010 |
| 295 |
OCULAR DISCOMFORT |
11 |
0.0010 |
| 296 |
LIVER FUNCTION TEST INCREASED |
21 |
0.0010 |
| 297 |
IRON DEFICIENCY ANAEMIA |
9 |
0.0010 |
| 298 |
CHOLANGITIS |
6 |
0.0010 |
| 299 |
PRODUCT DISPENSING ERROR |
21 |
0.0010 |
| 300 |
INTENTIONAL PRODUCT MISUSE |
83 |
0.0009 |
| 301 |
HYPERHIDROSIS |
121 |
0.0009 |
| 302 |
BODY TEMPERATURE INCREASED |
19 |
0.0009 |
| 303 |
POOR QUALITY DRUG ADMINISTERED |
6 |
0.0009 |
| 304 |
BLOOD MAGNESIUM DECREASED |
8 |
0.0009 |
| 305 |
LIMB INJURY |
25 |
0.0009 |
| 306 |
HEPATIC NEOPLASM |
3 |
0.0009 |
| 307 |
HIP ARTHROPLASTY |
14 |
0.0009 |
| 308 |
INTENTIONAL DOSE OMISSION |
26 |
0.0009 |
| 309 |
PRODUCT DOSE OMISSION ISSUE |
268 |
0.0009 |
| 310 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
64 |
0.0009 |
| 311 |
MENINGITIS |
6 |
0.0009 |
| 312 |
INFECTIOUS MONONUCLEOSIS |
2 |
0.0009 |
| 313 |
ABDOMINAL DISTENSION |
93 |
0.0009 |
| 314 |
BLOOD CALCIUM DECREASED |
10 |
0.0009 |
| 315 |
ABDOMINAL HERNIA |
4 |
0.0009 |
| 316 |
CHOLECYSTECTOMY |
10 |
0.0009 |
| 317 |
EAR DISORDER |
4 |
0.0009 |
| 318 |
TEMPERATURE INTOLERANCE |
9 |
0.0009 |
| 319 |
LARGE INTESTINE POLYP |
6 |
0.0009 |
| 320 |
HAEMANGIOMA |
2 |
0.0009 |
| 321 |
HYPERVENTILATION |
5 |
0.0009 |
| 322 |
CONTUSION |
83 |
0.0009 |
| 323 |
INJECTION SITE REACTION |
59 |
0.0009 |
| 324 |
ILLNESS |
88 |
0.0009 |
| 325 |
HEPATOTOXICITY |
19 |
0.0009 |
| 326 |
INJECTION SITE PAIN |
261 |
0.0009 |
| 327 |
PANCREATITIS CHRONIC |
2 |
0.0008 |
| 328 |
DIVERTICULUM |
6 |
0.0008 |
| 329 |
PERIPHERAL SWELLING |
128 |
0.0008 |
| 330 |
HEPATITIS CHOLESTATIC |
5 |
0.0008 |
| 331 |
INJECTION SITE HAEMORRHAGE |
66 |
0.0008 |
| 332 |
BURSITIS |
10 |
0.0008 |
| 333 |
ADRENAL INSUFFICIENCY |
10 |
0.0008 |
| 334 |
DEVICE BREAKAGE |
33 |
0.0008 |
| 335 |
PRODUCT DOSE OMISSION |
53 |
0.0008 |
| 336 |
PRE-EXISTING CONDITION IMPROVED |
5 |
0.0008 |
| 337 |
PARANASAL SINUS HYPERSECRETION |
3 |
0.0008 |
| 338 |
ABDOMINAL INFECTION |
2 |
0.0008 |
| 339 |
PHLEBITIS |
4 |
0.0008 |
| 340 |
SKELETAL INJURY |
8 |
0.0008 |
| 341 |
LIPOMA |
2 |
0.0008 |
| 342 |
EAR PAIN |
15 |
0.0008 |
| 343 |
FAECES HARD |
3 |
0.0008 |
| 344 |
HEPATITIS TOXIC |
2 |
0.0008 |
| 345 |
VULVOVAGINAL MYCOTIC INFECTION |
3 |
0.0008 |
| 346 |
CHOLECYSTITIS |
9 |
0.0008 |
| 347 |
BLOOD PRESSURE ABNORMAL |
15 |
0.0008 |
| 348 |
NASAL DISORDER |
2 |
0.0008 |
| 349 |
PRODUCT COMPLAINT |
19 |
0.0007 |
| 350 |
INTRACRANIAL ANEURYSM |
3 |
0.0007 |
| 351 |
ANAL FISSURE |
4 |
0.0007 |
| 352 |
LARYNGOSPASM |
2 |
0.0007 |
| 353 |
BLOOD SODIUM DECREASED |
14 |
0.0007 |
| 354 |
HIP SURGERY |
4 |
0.0007 |
| 355 |
PRESCRIBED OVERDOSE |
14 |
0.0007 |
| 356 |
ARTHRALGIA |
300 |
0.0007 |
| 357 |
NEOPLASM MALIGNANT |
48 |
0.0007 |
| 358 |
VITAMIN D DEFICIENCY |
7 |
0.0007 |
| 359 |
BLOOD UREA INCREASED |
12 |
0.0007 |
| 360 |
BLOOD PRESSURE FLUCTUATION |
17 |
0.0007 |
| 361 |
LIGAMENT SPRAIN |
7 |
0.0007 |
| 362 |
JOINT LOCK |
2 |
0.0007 |
| 363 |
ABSCESS LIMB |
3 |
0.0007 |
| 364 |
SHOULDER OPERATION |
3 |
0.0007 |
| 365 |
FEAR OF INJECTION |
5 |
0.0007 |
| 366 |
DRUG RESISTANCE |
18 |
0.0007 |
| 367 |
PRODUCT CONTAINER ISSUE |
6 |
0.0007 |
| 368 |
UNDERDOSE |
51 |
0.0007 |
| 369 |
HEART VALVE INCOMPETENCE |
2 |
0.0007 |
| 370 |
NEPHROLITHIASIS |
32 |
0.0007 |
| 371 |
FIBULA FRACTURE |
2 |
0.0007 |
| 372 |
HYPERTONIC BLADDER |
2 |
0.0007 |
| 373 |
INJECTION SITE HAEMATOMA |
10 |
0.0007 |
| 374 |
SLUGGISHNESS |
7 |
0.0007 |
| 375 |
CARDIAC FAILURE |
55 |
0.0007 |
| 376 |
LUMBAR SPINAL STENOSIS |
2 |
0.0007 |
| 377 |
BLOOD CALCIUM INCREASED |
6 |
0.0007 |
| 378 |
BLOOD PRESSURE DIASTOLIC DECREASED |
5 |
0.0007 |
| 379 |
SUSPECTED OFF LABEL USE |
3 |
0.0007 |
| 380 |
DRUG INTOLERANCE |
64 |
0.0007 |
| 381 |
INCONTINENCE |
7 |
0.0007 |
| 382 |
NECK PAIN |
37 |
0.0007 |
| 383 |
DISEASE COMPLICATION |
3 |
0.0007 |
| 384 |
BODY HEIGHT DECREASED |
7 |
0.0007 |
| 385 |
BOWEL MOVEMENT IRREGULARITY |
5 |
0.0007 |
| 386 |
GLOMERULAR FILTRATION RATE DECREASED |
8 |
0.0007 |
| 387 |
CARDIOMEGALY |
8 |
0.0006 |
| 388 |
BLOOD GLUCOSE INCREASED |
122 |
0.0006 |
| 389 |
HEADACHE |
404 |
0.0006 |
| 390 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
16 |
0.0006 |
| 391 |
GAIT DISTURBANCE |
123 |
0.0006 |
| 392 |
BRADYCARDIA |
34 |
0.0006 |
| 393 |
INJECTION SITE NODULE |
7 |
0.0006 |
| 394 |
FLATULENCE |
36 |
0.0006 |
| 395 |
FAECAL CALPROTECTIN INCREASED |
2 |
0.0006 |
| 396 |
PRODUCT PACKAGING ISSUE |
6 |
0.0006 |
| 397 |
GESTATIONAL DIABETES |
3 |
0.0006 |
| 398 |
EYE INFLAMMATION |
6 |
0.0006 |
| 399 |
DEVICE USE ISSUE |
11 |
0.0006 |
| 400 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
29 |
0.0006 |
| 401 |
LOOSE TOOTH |
2 |
0.0006 |
| 402 |
PORTAL VEIN THROMBOSIS |
2 |
0.0006 |
| 403 |
HEPATITIS ACUTE |
4 |
0.0006 |
| 404 |
DRUG DOSE OMISSION BY DEVICE |
48 |
0.0006 |
| 405 |
LABORATORY TEST ABNORMAL |
18 |
0.0006 |
| 406 |
PANCREATIC DISORDER |
3 |
0.0006 |
| 407 |
INCORRECT PRODUCT STORAGE |
8 |
0.0006 |
| 408 |
CORONAVIRUS INFECTION |
4 |
0.0006 |
| 409 |
CYTOLYTIC HEPATITIS |
2 |
0.0006 |
| 410 |
ATRIAL FIBRILLATION |
58 |
0.0006 |
| 411 |
BACK PAIN |
138 |
0.0006 |
| 412 |
HAEMORRHAGE |
62 |
0.0006 |
| 413 |
DYSLIPIDAEMIA |
3 |
0.0006 |
| 414 |
MUSCULAR WEAKNESS |
67 |
0.0006 |
| 415 |
JOINT SWELLING |
71 |
0.0006 |
| 416 |
BENIGN PROSTATIC HYPERPLASIA |
3 |
0.0006 |
| 417 |
VARICOSE VEIN |
3 |
0.0006 |
| 418 |
ENCEPHALITIS |
4 |
0.0006 |
| 419 |
HYPERGLYCAEMIA |
21 |
0.0006 |
| 420 |
TONSILLITIS |
3 |
0.0006 |
| 421 |
HAEMOGLOBIN DECREASED |
59 |
0.0006 |
| 422 |
INFLUENZA |
64 |
0.0006 |
| 423 |
OSTEOARTHRITIS |
24 |
0.0006 |
| 424 |
DIABETES MELLITUS INADEQUATE CONTROL |
10 |
0.0006 |
| 425 |
TYPE 2 DIABETES MELLITUS |
19 |
0.0006 |
| 426 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 427 |
JOINT INJURY |
12 |
0.0006 |
| 428 |
OFF LABEL USE |
491 |
0.0006 |
| 429 |
ABDOMINAL DISCOMFORT |
94 |
0.0006 |
| 430 |
INJECTION SITE DISCOLOURATION |
7 |
0.0006 |
| 431 |
SUBDURAL HAEMATOMA |
8 |
0.0006 |
| 432 |
PARALYSIS |
8 |
0.0006 |
| 433 |
INJECTION SITE DISCHARGE |
3 |
0.0006 |
| 434 |
HAEMATOCRIT DECREASED |
11 |
0.0006 |
| 435 |
BACK DISORDER |
9 |
0.0006 |
| 436 |
TONGUE DISORDER |
4 |
0.0006 |
| 437 |
NORMAL NEWBORN |
3 |
0.0006 |
| 438 |
NASOPHARYNGITIS |
101 |
0.0005 |
| 439 |
HEPATITIS |
14 |
0.0005 |
| 440 |
PRODUCT PRESCRIBING ERROR |
13 |
0.0005 |
| 441 |
PRODUCT PHYSICAL ISSUE |
11 |
0.0005 |
| 442 |
SWELLING |
51 |
0.0005 |
| 443 |
DEAFNESS UNILATERAL |
3 |
0.0005 |
| 444 |
INJECTION SITE SWELLING |
41 |
0.0005 |
| 445 |
ABDOMINAL PAIN UPPER |
110 |
0.0005 |
| 446 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 447 |
HEPATIC CIRRHOSIS |
10 |
0.0005 |
| 448 |
PARANASAL SINUS DISCOMFORT |
2 |
0.0005 |
| 449 |
HYPOAESTHESIA |
79 |
0.0005 |
| 450 |
URINARY TRACT INFECTION |
90 |
0.0005 |
| 451 |
RHINORRHOEA |
34 |
0.0005 |
| 452 |
CARDIAC VALVE DISEASE |
3 |
0.0005 |
| 453 |
CLAVICLE FRACTURE |
2 |
0.0005 |
| 454 |
ARTHROPATHY |
29 |
0.0005 |
| 455 |
OESOPHAGEAL ULCER |
2 |
0.0005 |
| 456 |
BLOOD URIC ACID INCREASED |
3 |
0.0005 |
| 457 |
HYPOGLYCAEMIA |
25 |
0.0005 |
| 458 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
92 |
0.0005 |
| 459 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 460 |
HUNGER |
7 |
0.0005 |
| 461 |
THYROID CANCER |
6 |
0.0005 |
| 462 |
FATIGUE |
387 |
0.0005 |
| 463 |
GALLBLADDER OPERATION |
2 |
0.0005 |
| 464 |
TENSION |
3 |
0.0005 |
| 465 |
WEIGHT INCREASED |
110 |
0.0005 |
| 466 |
CHROMATURIA |
11 |
0.0005 |
| 467 |
PRODUCT PREPARATION ERROR |
10 |
0.0005 |
| 468 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 469 |
AORTIC DISSECTION |
2 |
0.0005 |
| 470 |
LIVER FUNCTION TEST ABNORMAL |
14 |
0.0005 |
| 471 |
WEIGHT FLUCTUATION |
5 |
0.0005 |
| 472 |
DYSPNOEA EXERTIONAL |
18 |
0.0005 |
| 473 |
OROPHARYNGEAL PAIN |
43 |
0.0005 |
| 474 |
WEIGHT DECREASED |
129 |
0.0005 |
| 475 |
PAIN IN JAW |
13 |
0.0005 |
| 476 |
MALAISE |
201 |
0.0005 |
| 477 |
IMMOBILE |
2 |
0.0005 |
| 478 |
DIVERTICULUM INTESTINAL |
2 |
0.0005 |
| 479 |
GASTROINTESTINAL PAIN |
5 |
0.0005 |
| 480 |
PRODUCT COMMUNICATION ISSUE |
4 |
0.0005 |
| 481 |
LIGAMENT RUPTURE |
2 |
0.0005 |
| 482 |
MUSCULOSKELETAL CHEST PAIN |
7 |
0.0005 |
| 483 |
UPPER LIMB FRACTURE |
9 |
0.0005 |
| 484 |
DEHYDRATION |
60 |
0.0004 |
| 485 |
SKIN MASS |
3 |
0.0004 |
| 486 |
FACIAL PAIN |
4 |
0.0004 |
| 487 |
BRAIN FOG |
7 |
0.0004 |
| 488 |
RASH PAPULAR |
10 |
0.0004 |
| 489 |
THERAPEUTIC RESPONSE UNEXPECTED |
20 |
0.0004 |
| 490 |
COUGH |
125 |
0.0004 |
| 491 |
HEAVY MENSTRUAL BLEEDING |
4 |
0.0004 |
| 492 |
DRUG EFFECT DELAYED |
2 |
0.0004 |
| 493 |
IMPAIRED GASTRIC EMPTYING |
6 |
0.0004 |
| 494 |
INFARCTION |
3 |
0.0004 |
| 495 |
DEVICE MECHANICAL ISSUE |
6 |
0.0004 |
| 496 |
CELLULITIS |
22 |
0.0004 |
| 497 |
ONYCHOCLASIS |
3 |
0.0004 |
| 498 |
DIVERTICULITIS |
12 |
0.0004 |
| 499 |
INJECTION SITE PRURITUS |
29 |
0.0004 |
| 500 |
LOCALISED OEDEMA |
2 |
0.0004 |
| 501 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 502 |
ABDOMINAL PAIN |
100 |
0.0004 |
| 503 |
EXTRASYSTOLES |
3 |
0.0004 |
| 504 |
HEPATIC FUNCTION ABNORMAL |
16 |
0.0004 |
| 505 |
LIVER DISORDER |
19 |
0.0004 |
| 506 |
CARPAL TUNNEL SYNDROME |
6 |
0.0004 |
| 507 |
FEELING ABNORMAL |
102 |
0.0004 |
| 508 |
NASAL CONGESTION |
25 |
0.0004 |
| 509 |
PRE-ECLAMPSIA |
2 |
0.0004 |
| 510 |
RED BLOOD CELL COUNT DECREASED |
12 |
0.0004 |
| 511 |
LIMB OPERATION |
2 |
0.0004 |
| 512 |
DEPRESSED MOOD |
22 |
0.0004 |
| 513 |
AMNESIA |
27 |
0.0004 |
| 514 |
TRANSIENT ISCHAEMIC ATTACK |
14 |
0.0004 |
| 515 |
PAIN IN EXTREMITY |
122 |
0.0004 |
| 516 |
MAJOR DEPRESSION |
3 |
0.0004 |
| 517 |
UTERINE LEIOMYOMA |
3 |
0.0004 |
| 518 |
COVID-19 |
72 |
0.0004 |
| 519 |
INCORRECT DOSAGE ADMINISTERED |
2 |
0.0004 |
| 520 |
ALANINE AMINOTRANSFERASE INCREASED |
25 |
0.0004 |
| 521 |
HYPOTHYROIDISM |
13 |
0.0004 |
| 522 |
PSYCHIATRIC SYMPTOM |
3 |
0.0004 |
| 523 |
NASAL POLYPS |
2 |
0.0004 |
| 524 |
TRANSAMINASES INCREASED |
9 |
0.0004 |
| 525 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 526 |
MUCOUS STOOLS |
2 |
0.0004 |
| 527 |
GASTROINTESTINAL SOUNDS ABNORMAL |
2 |
0.0004 |
| 528 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 529 |
DECREASED APPETITE |
93 |
0.0004 |
| 530 |
DIARRHOEA |
256 |
0.0004 |
| 531 |
PRODUCT ADMINISTRATION ERROR |
8 |
0.0004 |
| 532 |
HEAD DISCOMFORT |
7 |
0.0004 |
| 533 |
INJECTION SITE IRRITATION |
5 |
0.0004 |
| 534 |
SUBARACHNOID HAEMORRHAGE |
4 |
0.0004 |
| 535 |
THIRST |
7 |
0.0004 |
| 536 |
INJECTION SITE RASH |
12 |
0.0004 |
| 537 |
ENDOCARDITIS |
2 |
0.0004 |
| 538 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 539 |
ERECTILE DYSFUNCTION |
10 |
0.0004 |
| 540 |
CATARACT |
23 |
0.0004 |
| 541 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 542 |
VENTRICULAR EXTRASYSTOLES |
4 |
0.0004 |
| 543 |
NODULE |
5 |
0.0004 |
| 544 |
CONSTIPATION |
83 |
0.0004 |
| 545 |
GASTROINTESTINAL DISORDER |
34 |
0.0004 |
| 546 |
FEELING HOT |
23 |
0.0004 |
| 547 |
FOOD POISONING |
2 |
0.0004 |
| 548 |
HIP FRACTURE |
12 |
0.0004 |
| 549 |
OVERWEIGHT |
2 |
0.0004 |
| 550 |
PHOTOPHOBIA |
7 |
0.0004 |
| 551 |
BLOOD BILIRUBIN INCREASED |
10 |
0.0004 |
| 552 |
SINUS CONGESTION |
5 |
0.0004 |
| 553 |
BEHAVIOUR DISORDER |
2 |
0.0004 |
| 554 |
DECUBITUS ULCER |
3 |
0.0004 |
| 555 |
DEVICE ISSUE |
33 |
0.0004 |
| 556 |
HYDROCEPHALUS |
2 |
0.0004 |
| 557 |
ABNORMAL FAECES |
3 |
0.0004 |
| 558 |
BLOOD POTASSIUM DECREASED |
11 |
0.0004 |
| 559 |
HICCUPS |
3 |
0.0004 |
| 560 |
DEVICE DIFFICULT TO USE |
24 |
0.0004 |
| 561 |
HYPERKERATOSIS |
2 |
0.0004 |
| 562 |
HERNIA |
7 |
0.0004 |
| 563 |
NERVE INJURY |
4 |
0.0004 |
| 564 |
HAEMORRHOIDS |
7 |
0.0004 |
| 565 |
MYALGIA |
61 |
0.0004 |
| 566 |
DRUG EFFECT INCOMPLETE |
13 |
0.0004 |
| 567 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
2 |
0.0004 |
| 568 |
SENSATION OF FOREIGN BODY |
3 |
0.0004 |
| 569 |
EYE INFECTION |
4 |
0.0004 |
| 570 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
17 |
0.0004 |
| 571 |
SEASONAL ALLERGY |
5 |
0.0004 |
| 572 |
SWOLLEN TONGUE |
11 |
0.0004 |
| 573 |
GASTRIC DISORDER |
12 |
0.0003 |
| 574 |
CARDIAC OPERATION |
3 |
0.0003 |
| 575 |
EXERCISE TOLERANCE DECREASED |
2 |
0.0003 |
| 576 |
EXPOSURE VIA SKIN CONTACT |
9 |
0.0003 |
| 577 |
PAIN |
213 |
0.0003 |
| 578 |
MOUTH SWELLING |
2 |
0.0003 |
| 579 |
HYSTERECTOMY |
3 |
0.0003 |
| 580 |
MENTAL DISORDER |
15 |
0.0003 |
| 581 |
INJURY ASSOCIATED WITH DEVICE |
7 |
0.0003 |
| 582 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
9 |
0.0003 |
| 583 |
NAIL DISORDER |
3 |
0.0003 |
| 584 |
FALL |
113 |
0.0003 |
| 585 |
DECREASED INTEREST |
2 |
0.0003 |
| 586 |
ARRHYTHMIA |
16 |
0.0003 |
| 587 |
DRUG EFFECT LESS THAN EXPECTED |
5 |
0.0003 |
| 588 |
CARDIAC PACEMAKER INSERTION |
2 |
0.0003 |
| 589 |
MACULAR DEGENERATION |
4 |
0.0003 |
| 590 |
KNEE ARTHROPLASTY |
7 |
0.0003 |
| 591 |
DRUG INEFFECTIVE |
438 |
0.0003 |
| 592 |
BLOOD PRESSURE DECREASED |
22 |
0.0003 |
| 593 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 594 |
SKIN DISORDER |
11 |
0.0003 |
| 595 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
18 |
0.0003 |
| 596 |
RETINAL DETACHMENT |
3 |
0.0003 |
| 597 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
3 |
0.0003 |
| 598 |
NERVOUSNESS |
17 |
0.0003 |
| 599 |
MENISCUS INJURY |
2 |
0.0003 |
| 600 |
SPINAL OPERATION |
4 |
0.0003 |
| 601 |
ASTHENIA |
122 |
0.0003 |
| 602 |
EMOTIONAL DISORDER |
10 |
0.0003 |
| 603 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 604 |
VISUAL IMPAIRMENT |
40 |
0.0003 |
| 605 |
CONDITION AGGRAVATED |
98 |
0.0003 |
| 606 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 607 |
DRY EYE |
16 |
0.0003 |
| 608 |
MEMORY IMPAIRMENT |
44 |
0.0003 |
| 609 |
FLANK PAIN |
3 |
0.0003 |
| 610 |
BLINDNESS |
13 |
0.0003 |
| 611 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 612 |
PRODUCT USE COMPLAINT |
5 |
0.0003 |
| 613 |
SPINAL DISORDER |
3 |
0.0003 |
| 614 |
DISEASE RECURRENCE |
15 |
0.0003 |
| 615 |
ABSCESS |
5 |
0.0003 |
| 616 |
DISEASE PROGRESSION |
37 |
0.0003 |
| 617 |
AFFECT LABILITY |
3 |
0.0003 |
| 618 |
GLAUCOMA |
6 |
0.0003 |
| 619 |
GALACTORRHOEA |
2 |
0.0003 |
| 620 |
SINUS BRADYCARDIA |
3 |
0.0003 |
| 621 |
NIGHT SWEATS |
10 |
0.0003 |
| 622 |
DIZZINESS POSTURAL |
3 |
0.0003 |
| 623 |
BLOOD POTASSIUM INCREASED |
5 |
0.0003 |
| 624 |
DECREASED IMMUNE RESPONSIVENESS |
3 |
0.0003 |
| 625 |
VITREOUS FLOATERS |
3 |
0.0003 |
| 626 |
KNEE OPERATION |
3 |
0.0003 |
| 627 |
INFLUENZA LIKE ILLNESS |
25 |
0.0003 |
| 628 |
PYREXIA |
105 |
0.0003 |
| 629 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 630 |
SINUSITIS |
31 |
0.0003 |
| 631 |
HYPOACUSIS |
13 |
0.0003 |
| 632 |
APPETITE DISORDER |
2 |
0.0003 |
| 633 |
CEREBROVASCULAR ACCIDENT |
51 |
0.0003 |
| 634 |
EAR INFECTION |
8 |
0.0003 |
| 635 |
HYPOTONIA |
3 |
0.0003 |
| 636 |
OVARIAN CYST |
3 |
0.0003 |
| 637 |
GAIT INABILITY |
10 |
0.0003 |
| 638 |
DIZZINESS |
148 |
0.0003 |
| 639 |
EYELID PTOSIS |
3 |
0.0003 |
| 640 |
GENERAL PHYSICAL CONDITION ABNORMAL |
2 |
0.0003 |
| 641 |
MIGRAINE |
28 |
0.0003 |
| 642 |
CHEST DISCOMFORT |
30 |
0.0003 |
| 643 |
NAUSEA |
231 |
0.0003 |
| 644 |
INJECTION SITE ERYTHEMA |
36 |
0.0003 |
| 645 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 646 |
CARDIAC DISORDER |
27 |
0.0003 |
| 647 |
ROAD TRAFFIC ACCIDENT |
12 |
0.0003 |
| 648 |
DEMENTIA |
8 |
0.0003 |
| 649 |
CHEST PAIN |
53 |
0.0003 |
| 650 |
AGITATION |
21 |
0.0003 |
| 651 |
COLD SWEAT |
5 |
0.0003 |
| 652 |
SUDDEN DEATH |
3 |
0.0003 |
| 653 |
RENAL PAIN |
3 |
0.0003 |
| 654 |
CYSTITIS |
9 |
0.0003 |
| 655 |
HEPATOCELLULAR INJURY |
4 |
0.0003 |
| 656 |
DIALYSIS |
4 |
0.0003 |
| 657 |
BREAST PAIN |
3 |
0.0003 |
| 658 |
THERAPEUTIC RESPONSE DECREASED |
17 |
0.0003 |
| 659 |
HYPERSENSITIVITY |
52 |
0.0003 |
| 660 |
ANGINA PECTORIS |
8 |
0.0003 |
| 661 |
RENAL DISORDER |
13 |
0.0003 |
| 662 |
POOR QUALITY SLEEP |
6 |
0.0003 |
| 663 |
PANIC REACTION |
2 |
0.0003 |
| 664 |
TREATMENT NONCOMPLIANCE |
15 |
0.0003 |
| 665 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
5 |
0.0003 |
| 666 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
6 |
0.0003 |
| 667 |
CARDIOMYOPATHY |
4 |
0.0003 |
| 668 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0003 |
| 669 |
BRONCHITIS |
20 |
0.0003 |
| 670 |
ARTHROPOD BITE |
2 |
0.0003 |
| 671 |
HEPATIC STEATOSIS |
5 |
0.0003 |
| 672 |
COLON CANCER |
4 |
0.0003 |
| 673 |
BLISTER |
15 |
0.0003 |
| 674 |
JOINT STIFFNESS |
7 |
0.0003 |
| 675 |
BREAST TENDERNESS |
2 |
0.0003 |
| 676 |
ALOPECIA |
52 |
0.0003 |
| 677 |
HYPERTENSION |
56 |
0.0003 |
| 678 |
ASPARTATE AMINOTRANSFERASE INCREASED |
14 |
0.0003 |
| 679 |
SCAB |
3 |
0.0003 |
| 680 |
HEPATOCELLULAR CARCINOMA |
2 |
0.0003 |
| 681 |
PNEUMONIA |
85 |
0.0003 |
| 682 |
VERTIGO |
16 |
0.0003 |
| 683 |
ACIDOSIS |
2 |
0.0003 |
| 684 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 685 |
SEIZURE |
30 |
0.0003 |
| 686 |
TACHYCARDIA |
23 |
0.0003 |
| 687 |
CONCUSSION |
2 |
0.0003 |
| 688 |
APHTHOUS ULCER |
2 |
0.0003 |
| 689 |
NERVOUS SYSTEM DISORDER |
8 |
0.0003 |
| 690 |
DEVICE MALFUNCTION |
18 |
0.0003 |
| 691 |
MENORRHAGIA |
5 |
0.0003 |
| 692 |
SINUS DISORDER |
5 |
0.0003 |
| 693 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 694 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
9 |
0.0003 |
| 695 |
GINGIVAL PAIN |
2 |
0.0003 |
| 696 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 697 |
EYE PAIN |
14 |
0.0002 |
| 698 |
SPEECH DISORDER |
13 |
0.0002 |
| 699 |
NEURALGIA |
6 |
0.0002 |
| 700 |
PANCREATITIS |
13 |
0.0002 |
| 701 |
LETHARGY |
14 |
0.0002 |
| 702 |
INJECTION SITE WARMTH |
5 |
0.0002 |
| 703 |
PRODUCT QUALITY ISSUE |
33 |
0.0002 |
| 704 |
PHARYNGITIS |
3 |
0.0002 |
| 705 |
CYST |
3 |
0.0002 |
| 706 |
MENSTRUAL DISORDER |
2 |
0.0002 |
| 707 |
ILEUS |
3 |
0.0002 |
| 708 |
ANAEMIA |
46 |
0.0002 |
| 709 |
VISION BLURRED |
33 |
0.0002 |
| 710 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 711 |
MUSCULOSKELETAL STIFFNESS |
21 |
0.0002 |
| 712 |
PARAESTHESIA |
37 |
0.0002 |
| 713 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 714 |
INFLAMMATION |
12 |
0.0002 |
| 715 |
HIATUS HERNIA |
3 |
0.0002 |
| 716 |
PRURITUS GENERALISED |
5 |
0.0002 |
| 717 |
DIPLOPIA |
6 |
0.0002 |
| 718 |
DEATH |
199 |
0.0002 |
| 719 |
SYNCOPE |
23 |
0.0002 |
| 720 |
AMENORRHOEA |
4 |
0.0002 |
| 721 |
TOOTH INFECTION |
3 |
0.0002 |
| 722 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
2 |
0.0002 |
| 723 |
LYMPHADENOPATHY |
8 |
0.0002 |
| 724 |
ANXIETY |
64 |
0.0002 |
| 725 |
THROMBOSIS |
18 |
0.0002 |
| 726 |
JOINT RANGE OF MOTION DECREASED |
3 |
0.0002 |
| 727 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 728 |
THERAPY NON-RESPONDER |
10 |
0.0002 |
| 729 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 730 |
PULMONARY EMBOLISM |
21 |
0.0002 |
| 731 |
GASTROINTESTINAL CARCINOMA |
2 |
0.0002 |
| 732 |
LIP DRY |
2 |
0.0002 |
| 733 |
OSTEOPOROSIS |
9 |
0.0002 |
| 734 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 735 |
MUSCLE TWITCHING |
5 |
0.0002 |
| 736 |
OVARIAN CANCER |
2 |
0.0002 |
| 737 |
NERVE COMPRESSION |
2 |
0.0002 |
| 738 |
FLUID RETENTION |
11 |
0.0002 |
| 739 |
DYSARTHRIA |
8 |
0.0002 |
| 740 |
HEART RATE INCREASED |
21 |
0.0002 |
| 741 |
LEUKAEMIA |
2 |
0.0002 |
| 742 |
FOOT FRACTURE |
4 |
0.0002 |
| 743 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
15 |
0.0002 |
| 744 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 745 |
MUSCULOSKELETAL DISORDER |
4 |
0.0002 |
| 746 |
RECTAL HAEMORRHAGE |
9 |
0.0002 |
| 747 |
INCREASED APPETITE |
4 |
0.0002 |
| 748 |
CHOLESTASIS |
4 |
0.0002 |
| 749 |
POST PROCEDURAL COMPLICATION |
4 |
0.0002 |
| 750 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 751 |
DIABETIC KETOACIDOSIS |
5 |
0.0002 |
| 752 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 753 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 754 |
ANGER |
7 |
0.0002 |
| 755 |
DEPRESSION |
47 |
0.0002 |
| 756 |
MENTAL IMPAIRMENT |
5 |
0.0002 |
| 757 |
ASTHMA |
23 |
0.0002 |
| 758 |
PULMONARY MASS |
3 |
0.0002 |
| 759 |
SWELLING FACE |
13 |
0.0002 |
| 760 |
BLOOD CREATININE INCREASED |
13 |
0.0002 |
| 761 |
TREMOR |
33 |
0.0002 |
| 762 |
SLEEP DISORDER |
14 |
0.0002 |
| 763 |
INCORRECT DOSE ADMINISTERED |
45 |
0.0002 |
| 764 |
CEREBRAL HAEMORRHAGE |
7 |
0.0002 |
| 765 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 766 |
ANAPHYLACTIC SHOCK |
5 |
0.0002 |
| 767 |
ANKLE FRACTURE |
3 |
0.0002 |
| 768 |
INSOMNIA |
51 |
0.0002 |
| 769 |
MUSCLE SPASMS |
35 |
0.0002 |
| 770 |
JOINT DISLOCATION |
2 |
0.0002 |
| 771 |
DYSPNOEA |
107 |
0.0002 |
| 772 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 773 |
MENSTRUATION DELAYED |
2 |
0.0002 |
| 774 |
CLOSTRIDIUM DIFFICILE INFECTION |
4 |
0.0002 |
| 775 |
VOMITING |
86 |
0.0002 |
| 776 |
EYE DISORDER |
6 |
0.0002 |
| 777 |
BREAST CANCER |
17 |
0.0002 |
| 778 |
HAEMATOCHEZIA |
10 |
0.0002 |
| 779 |
TREATMENT FAILURE |
15 |
0.0002 |
| 780 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 781 |
RENAL IMPAIRMENT |
15 |
0.0002 |
| 782 |
PANCREATITIS ACUTE |
4 |
0.0002 |
| 783 |
OXYGEN SATURATION DECREASED |
10 |
0.0002 |
| 784 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 785 |
DISORIENTATION |
7 |
0.0002 |
| 786 |
SCAR |
3 |
0.0002 |
| 787 |
MICTURITION URGENCY |
2 |
0.0002 |
| 788 |
PANCREATIC CARCINOMA |
5 |
0.0002 |
| 789 |
LOSS OF CONSCIOUSNESS |
22 |
0.0002 |
| 790 |
BACTERAEMIA |
2 |
0.0002 |
| 791 |
POLLAKIURIA |
7 |
0.0002 |
| 792 |
RESPIRATORY DISORDER |
5 |
0.0002 |
| 793 |
MOBILITY DECREASED |
12 |
0.0002 |
| 794 |
DISTURBANCE IN ATTENTION |
9 |
0.0002 |
| 795 |
TOOTHACHE |
3 |
0.0002 |
| 796 |
OSTEOMYELITIS |
3 |
0.0002 |
| 797 |
LOCALISED INFECTION |
4 |
0.0002 |
| 798 |
CRYING |
6 |
0.0002 |
| 799 |
FIBROMYALGIA |
4 |
0.0002 |
| 800 |
PRESYNCOPE |
4 |
0.0002 |
| 801 |
DISCOMFORT |
10 |
0.0002 |
| 802 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
| 803 |
SEPSIS |
18 |
0.0002 |
| 804 |
THINKING ABNORMAL |
3 |
0.0002 |
| 805 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 806 |
FRACTURE |
3 |
0.0002 |
| 807 |
COLITIS |
6 |
0.0002 |
| 808 |
HEAD INJURY |
5 |
0.0002 |
| 809 |
PROTEINURIA |
3 |
0.0002 |
| 810 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 811 |
INTRAOCULAR PRESSURE INCREASED |
2 |
0.0002 |
| 812 |
OEDEMA PERIPHERAL |
19 |
0.0002 |
| 813 |
URTICARIA |
26 |
0.0002 |
| 814 |
SKIN ULCER |
4 |
0.0002 |
| 815 |
DYSPHONIA |
9 |
0.0002 |
| 816 |
PALPITATIONS |
18 |
0.0002 |
| 817 |
CHILLS |
18 |
0.0002 |
| 818 |
DEAFNESS |
4 |
0.0002 |
| 819 |
KIDNEY INFECTION |
3 |
0.0002 |
| 820 |
HAND DEFORMITY |
2 |
0.0002 |
| 821 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 822 |
DYSMENORRHOEA |
2 |
0.0002 |
| 823 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 824 |
VIRAL INFECTION |
5 |
0.0002 |
| 825 |
COGNITIVE DISORDER |
7 |
0.0001 |
| 826 |
ABORTION SPONTANEOUS |
6 |
0.0001 |
| 827 |
SPINAL FRACTURE |
3 |
0.0001 |
| 828 |
HAIR TEXTURE ABNORMAL |
2 |
0.0001 |
| 829 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 830 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 831 |
FEEDING DISORDER |
3 |
0.0001 |
| 832 |
OEDEMA |
8 |
0.0001 |
| 833 |
EPISTAXIS |
11 |
0.0001 |
| 834 |
MOOD ALTERED |
4 |
0.0001 |
| 835 |
HOT FLUSH |
11 |
0.0001 |
| 836 |
RIB FRACTURE |
3 |
0.0001 |
| 837 |
TOOTH LOSS |
3 |
0.0001 |
| 838 |
APHONIA |
2 |
0.0001 |
| 839 |
BLINDNESS UNILATERAL |
2 |
0.0001 |
| 840 |
HERPES ZOSTER |
8 |
0.0001 |
| 841 |
ALTERED STATE OF CONSCIOUSNESS |
3 |
0.0001 |
| 842 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 843 |
INTENTIONAL PRODUCT USE ISSUE |
12 |
0.0001 |
| 844 |
GASTROOESOPHAGEAL REFLUX DISEASE |
11 |
0.0001 |
| 845 |
SURGERY |
8 |
0.0001 |
| 846 |
THERAPY CESSATION |
7 |
0.0001 |
| 847 |
ERYTHEMA |
28 |
0.0001 |
| 848 |
ASCITES |
4 |
0.0001 |
| 849 |
EYE SWELLING |
5 |
0.0001 |
| 850 |
PRURITUS |
51 |
0.0001 |
| 851 |
INTESTINAL OBSTRUCTION |
5 |
0.0001 |
| 852 |
DYSPEPSIA |
13 |
0.0001 |
| 853 |
ACNE |
10 |
0.0001 |
| 854 |
OSTEOPENIA |
2 |
0.0001 |
| 855 |
DRUG DISPENSING ERROR |
2 |
0.0001 |
| 856 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 857 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 858 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 859 |
HYPOTENSION |
26 |
0.0001 |
| 860 |
DELUSION |
2 |
0.0001 |
| 861 |
DRUG-INDUCED LIVER INJURY |
4 |
0.0001 |
| 862 |
DRUG DOSE OMISSION |
21 |
0.0001 |
| 863 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 864 |
MYOCARDIAL INFARCTION |
22 |
0.0001 |
| 865 |
OBESITY |
2 |
0.0001 |
| 866 |
EXTRA DOSE ADMINISTERED |
5 |
0.0001 |
| 867 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
25 |
0.0001 |
| 868 |
INJECTION SITE URTICARIA |
3 |
0.0001 |
| 869 |
LIVER INJURY |
3 |
0.0001 |
| 870 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 871 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 872 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 873 |
RASH |
52 |
0.0001 |
| 874 |
SOMNOLENCE |
24 |
0.0001 |
| 875 |
GASTRIC CANCER |
3 |
0.0001 |
| 876 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 877 |
HAEMATURIA |
4 |
0.0001 |
| 878 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 879 |
BALANCE DISORDER |
10 |
0.0001 |
| 880 |
DEVICE USE ERROR |
4 |
0.0001 |
| 881 |
LOCAL SWELLING |
2 |
0.0001 |
| 882 |
RENAL FAILURE |
15 |
0.0001 |
| 883 |
GENERAL PHYSICAL HEALTH DETERIORATION |
13 |
0.0001 |
| 884 |
MATERNAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 885 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 886 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 887 |
GOUT |
2 |
0.0001 |
| 888 |
CONFUSIONAL STATE |
18 |
0.0001 |
| 889 |
THROAT TIGHTNESS |
3 |
0.0001 |
| 890 |
PALLOR |
3 |
0.0001 |
| 891 |
PANIC ATTACK |
4 |
0.0001 |
| 892 |
TINNITUS |
5 |
0.0001 |
| 893 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 894 |
DYSPHAGIA |
10 |
0.0001 |
| 895 |
GASTRIC ULCER |
2 |
0.0001 |
| 896 |
NEUROPATHY PERIPHERAL |
10 |
0.0001 |
| 897 |
PRODUCTIVE COUGH |
5 |
0.0001 |
| 898 |
HYPERSOMNIA |
3 |
0.0001 |
| 899 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 900 |
DRUG PRESCRIBING ERROR |
2 |
0.0001 |
| 901 |
PRODUCT STORAGE ERROR |
9 |
0.0001 |
| 902 |
DYSSTASIA |
3 |
0.0001 |
| 903 |
MULTIPLE SCLEROSIS RELAPSE |
7 |
0.0001 |
| 904 |
LEUKOPENIA |
5 |
0.0001 |
| 905 |
BURNING SENSATION |
7 |
0.0001 |
| 906 |
CARDIAC FAILURE CONGESTIVE |
8 |
0.0001 |
| 907 |
PROSTATE CANCER |
8 |
0.0001 |
| 908 |
EPILEPSY |
3 |
0.0001 |
| 909 |
DRY SKIN |
13 |
0.0001 |
| 910 |
CARDIAC ARREST |
8 |
0.0001 |
| 911 |
FEMUR FRACTURE |
3 |
0.0001 |
| 912 |
EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 913 |
RESPIRATORY FAILURE |
7 |
0.0001 |
| 914 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
5 |
0.0001 |
| 915 |
DERMATITIS |
2 |
0.0001 |
| 916 |
RENAL FAILURE ACUTE |
4 |
0.0001 |
| 917 |
MOOD SWINGS |
3 |
0.0001 |
| 918 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 919 |
DRUG EFFECT DECREASED |
5 |
0.0001 |
| 920 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
| 921 |
SEPTIC SHOCK |
4 |
0.0001 |
| 922 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 923 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 924 |
URINARY RETENTION |
3 |
0.0001 |
| 925 |
INFECTION |
13 |
0.0001 |
| 926 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 927 |
SUICIDAL IDEATION |
8 |
0.0001 |
| 928 |
ACCIDENTAL EXPOSURE TO PRODUCT |
9 |
0.0001 |
| 929 |
DELIRIUM |
3 |
0.0001 |
| 930 |
RASH MACULAR |
3 |
0.0001 |
| 931 |
COMA |
4 |
0.0001 |
| 932 |
RENAL CANCER |
4 |
0.0001 |
| 933 |
IRRITABILITY |
5 |
0.0001 |
| 934 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 935 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 936 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 937 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 938 |
ABASIA |
2 |
0.0001 |
| 939 |
AGGRESSION |
4 |
0.0001 |
| 940 |
CARDIOVASCULAR DISORDER |
2 |
0.0001 |
| 941 |
BREAST CANCER FEMALE |
2 |
0.0001 |
| 942 |
FEAR |
2 |
0.0001 |
| 943 |
DRY MOUTH |
6 |
0.0001 |
| 944 |
RASH PRURITIC |
4 |
0.0001 |
| 945 |
DEVICE DELIVERY SYSTEM ISSUE |
2 |
0.0001 |
| 946 |
HYPONATRAEMIA |
4 |
0.0001 |
| 947 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 948 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 949 |
ANGIOEDEMA |
3 |
0.0001 |
| 950 |
COLITIS ULCERATIVE |
3 |
0.0001 |
| 951 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 952 |
PREMATURE BABY |
2 |
0.0001 |
| 953 |
APHASIA |
2 |
0.0001 |
| 954 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 955 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 956 |
PLATELET COUNT DECREASED |
7 |
0.0001 |
| 957 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 958 |
GYNAECOMASTIA |
2 |
0.0001 |
| 959 |
PRODUCT USE IN UNAPPROVED INDICATION |
16 |
0.0001 |
| 960 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
| 961 |
LUNG DISORDER |
3 |
0.0001 |
| 962 |
OVERDOSE |
13 |
0.0001 |
| 963 |
FUNGAL INFECTION |
2 |
0.0001 |
| 964 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 965 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 966 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 967 |
WHEEZING |
3 |
0.0001 |
| 968 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 969 |
EMOTIONAL DISTRESS |
6 |
0.0000 |
| 970 |
STOMATITIS |
3 |
0.0000 |
| 971 |
FLUSHING |
5 |
0.0000 |
| 972 |
RHEUMATOID ARTHRITIS |
5 |
0.0000 |
| 973 |
HALLUCINATION |
3 |
0.0000 |
| 974 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 975 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 976 |
HOSPITALISATION |
6 |
0.0000 |
| 977 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 978 |
PANCYTOPENIA |
2 |
0.0000 |
| 979 |
BLADDER CANCER |
2 |
0.0000 |
| 980 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 981 |
DRUG INTERACTION |
5 |
0.0000 |
| 982 |
DYSGEUSIA |
2 |
0.0000 |
| 983 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 984 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 985 |
PSORIASIS |
3 |
0.0000 |
| 986 |
NEUTROPENIA |
3 |
0.0000 |
| 987 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 988 |
DRUG DEPENDENCE |
2 |
0.0000 |